New Treatment Recommended for Refractory MAC Lung Disease
source: pixabay.com

New Treatment Recommended for Refractory MAC Lung Disease

According to a story from PR Newswire, new international treatment recommendation guidelines have recently been updated for nontuberculous mycobacterial (NTM) lung disease. The update pertains to a variant known as Mycobacterium…

Continue Reading New Treatment Recommended for Refractory MAC Lung Disease
Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease
jniittymaa0 / Pixabay

Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease

A new drug designed to treat MAC lung disease as part of a combination antibacterial drug regimen in adults with limited treatment options has been granted Accelerated Approval by the…

Continue Reading Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease